ALKINDI gran 1 mg gélules à ouvrir fl 50 pce
7680682260027
CH-68226
H02AB09
07.07.21
Reimbursement limitations:
ALKINDI
Pour des doses fractionnées ≥5 mg ainsi que pour >3 doses fractionnées par jour, une …
1 / 3
google
Details
- Product number
- 6822602
- CPT
- -
- Packaging group
- 50
- Unit
- Kapsel(n)
- Composition
- hydrocortisonum 1 mg, cellulosum microcristallinum, hypromellosum, magnesii stearas, ethylcellulosum ad granulatum pro dosi.
Articles (1)
Alkindi 1 mg, Granulat zum Einnehmen
Granulat
50
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
1.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 80.30
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/02/2023
Authorization holder
EffRx Pharmaceuticals SA
8807 Freienbach
Authorization information
- Swissmedic authorization number
- 68226
- Drug name
- Alkindi, Granulat zum Einnehmen
- Galenic form
- GRAO
- ATC Code
- H02AB09
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 21/10/2021
- Authorization expiration date
- 20/10/2026
- IT number
- 07.07.21
- Domain
- Human medicine
Packaging details
- Description (FR)
- ALKINDI gran 1 mg gélules à ouvrir fl 50 pce
- Description (DE)
- ALKINDI Gran 1 mg Kapseln zum Öffnen Fl 50 Stk
- Market launch
- 21/10/2021
- Narcotic (BTM)
- No